Twitter Beğeni Hilesi

38y, male, severe LVD (myocarditis). After optimiziting meds, new TTE:biventricular dysfunction + severe MR (INTERMACS 5). Criteria for ❤️ transplant. MitraBridge! 2 XTWs.

LAD CTO. AWE , set up: Left Rad (6Fr JR), RFA (7Fr EBU). MC Mamba - Judo6/Provia9 failed - reentry w/ Fighter - Final 2 DES (provisional Dg)

Valve In Rio 2023 on the way! instagram.com/stories/mtebet…

CHIP day Uerj Oficial HUPE UERJ Case 1 🧔🏻‍♂️51y/o, SCAD Set up: LRA JR 6Fr /RFA AL1 7Fr MC Mamba 135 & 150cm Guidezilla 6Fr Ant & 7Fr Retro BASE to start —> RCART to finish 4 DES IVUS guided

CHIP day @UERJ_oficial HUPE UERJ Case 2 🧔🏻‍♂️49y/o, SCAD, + Treadmill test J CTO 2 (long/blunt) Set up: RRA EBU 7Fr /RFA AL1 7Fr MC Mamba 135 & 150cm Guidezilla 7Fr Ant &Retro Power BASE to start —> RCART 4 DES IVUS guided 2h30’ / 200ml / 5 Gy

Spitting Valsalva on TEE Monica Alcantara M.D. , MSc, FESC, FEACVI PFO or ASD ? #cardiologiador

Sessão inovadora baseada em casos clínicos!

Last LAAO of the year, big one, 35mm device, TEE guided. 16 cases in 2023 and huge confidence w/ the Watcman FLX device. Cleverson Zukowski Monica Alcantara M.D. , MSc, FESC, FEACVI Marden Tebet Vinicius Esteves,MD PhD FESC Rede D'Or @UERJ_oficial Mauricio Oliveira Esmeralci Ferreira Alex Felix Evandro Martins F. MD ANDRE CASARSA

Best in class Luigi RTHahnMD #valveinrio24

Don’t miss it . Great faculty, awesome programme and lot of interaction!

Male 77y/o, AF w/ DOAC related bleeding. 2 angioCT (8 months difference) performed by same team/technique pre sizing for LAAO closure. Which one u pick? #valveinrio #laao

Can we clear arterial atherosclerotic plaques? The ACC.24 Late-Breaking Clinical Trials have been announced. My highlight is the large, phase 3, multicenter, double-blind, randomized, placebo-controlled AEGIS-II trial, a study of CSL112 (apolipoprotein A-I) infusion in patients

An amazing international faculty in Valve in Rio 2024. Don’t miss, valveinrio.com thomas modine Didier Tchetche Vinicius Esteves,MD PhD FESC Cristiano Guedes Bezerra Felipe Maia, MD, MSc Maurizio taramasso Matias Sztejfman Gui Attizzani RTHahnMD Hemal Gada bernard prendergast Azeem Latib Evandro Martins F. MD Duane Pinto MD MPH

Final Count Down⏰ready to🚀 Valve in Rio De 14 a 15 de março Hotel Fairmont Copacabana – Rio de Janeiro #ValveInRio #ValveInRio2024 #Transcateter #DoençasValvares #Valvopatia #Cardiologia #TAVI #CardiologiaDor #intervencaovalvar

Consulta pública sobre a incorporação da tecnologia do fechamento de apêndice atrial esquerdo - terapia essencial para prover maior segurança nos pacientes que não toleram anticoagulação! Acessem!! instagram.com/stories/mtebet…

Omega study - Interim data from the first 100 patients was presented this morning by Prof Horst Sievert at the Late Breaking Trials session at CSI congress to a full house! #csi2024 #OmegaLAA #structuralheart

Brazilian storm at #CSIFRANKFURT2024! 💚💛💚💛Felipe Maia, MD, MSc Dr. Daniel Peralta Alex Felix Márcio Mendes Tamara Katina Rafael Modesto Rodolfo Lustosa Ana Paula Siciliano ANDRE CASARSA Cleverson Zukowski Vinicius Esteves,MD PhD FESC

Proud to present our experience with complex TAVI cases at CSI Conference in Frankfurt. Great session and debate w/ worldwide panel. Cleverson Zukowski Monica Alcantara M.D. , MSc, FESC, FEACVI Dr. Daniel Peralta Marden Tebet Vinicius Esteves,MD PhD FESC Rede D'Or Andre Casarsa Marques CSI Congress Renato Kaufman

#picplaypost

77y/o, 👴🏽, GI 🩸 on DOAC. Chicken wing anatomy - LAAO - Amulet 25mm. TOE guidance (no residual leak) . DAPT or 1/2 dose Apixaban 1st 3 mon FUP? Monica Alcantara M.D. , MSc, FESC, FEACVI Marden Tebet Felipe Monge HUPE UERJ Alex Felix Esmeralci Ferreira Dr. Daniel Peralta Aπόστολος Τζήκας Vivek Y. Reddy